Clinical Trials Directory

Trials / Completed

CompletedNCT00904163

Characteristics of Adult Patients With Recessive Dystrophic Epidermolysis Bullosa

Status
Completed
Phase
Study type
Observational
Enrollment
13 (actual)
Sponsor
Stanford University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Recessive dystrophic epidermolysis bullosa (RDEB) is a severe inherited blistering disease caused by the absence of type VII collagen. Patients with RDEB develop large, severely painful blisters and open wounds from minor trauma to their skin. We are screening RDEB subjects to determine additional characteristics of patients who survive to adulthood.

Conditions

Timeline

Start date
2009-04-01
Primary completion
2014-05-01
Completion
2014-05-01
First posted
2009-05-19
Last updated
2014-05-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00904163. Inclusion in this directory is not an endorsement.